5 reasons why quality management needs a GxP-regulated cloud

The global shift from traditional IT offerings to cloud services continues

picture of

Breaking News

Pfizer’s palbociclib is the top breast cancer drug used in clinical trials initiated in 2018

Breast cancer is the most commonly diagnosed cancer in women and is the fifth largest cause of cancer mortality ...

Adents serialisation solution chosen by French pharma company to ensure FMD compliance

Cloud solution enables Cristers to easily exchange serialisation data with supply chain partners and move beyond ...

Advanced Clinical announces new office location at Partnerships in Clinical Trials Europe

Advanced Clinical is a global clinical development organisation that provides CRO, FSP, quality and validation, and ...

EU GMP Annex 1: What's new for cleaning and disinfection

The revised Annex 1 of the GMP guidelines is close to publication. Here, James Tucker, Ecolab Life Sciences, explores ...

PCI Clinical Services to showcase expertise in Phase I clinical trials in Australia

The global healthcare industry trusts PCI for the drug development solutions that increase their products’ speed to ...

Pharma companies may miss crucial EU drug packaging deadline with a no-deal Brexit

Many EU and US pharma companies are unaware that if a no-deal Brexit is reached between the UK and the EU, they will ...

Serialisation and data connectivity: Part II

The new wrinkle in your supply chain, click here to read part I

New NSF training centre helps medical device makers comply with EU regulations

NSF International's comprehensive EU medical device and pharmaceutical regulatory compliance training is available in a ...

Recipharm’s proprietary molecule Erdosteine recognised as COPD treatment

Recipharm has announced that its proprietary molecule Erdosteine has been officially recognised by the GOLD (Global ...

The Brexit effect and the outlook for 2019

A Q&A with Richard Pether, Director, Rotech

Serialisation and data connectivity: Part I

The new wrinkle in your supply chain

Preparing PIs for post EU-FMD success

Ian Haynes of Excellis Europe explains how the company’s unique approach to enabling collaboration between parallel ...

Asceneuron initiates neuroimaging trial for tau modifier ASN120290

Major milestone in development of novel treatment for progressive supranuclear palsy and other tau-related dementias

CordenPharma announces successful SafeBridge recertification in CordenPharma Colorado

CordenPharma Colorado has successfully completed the potent compound recertification audit by SafeBridge Consultants